Here are four points:
1. The company previously had a rating of “outperform.”
2. The 52-week high of the share price is $47.12, and the 52-week low is $18.95.
3. The company has a market cap of $624 million.
4. Currently, company insiders own 12.4 percent of LDR.
More articles on devices:
Australian researcher creates new spinal fusion device: 6 insights
LDR Holding partners with Poly-Shape for spinal implant manufacturing: 5 points
Global hip, knee orthopedic surgical robots market to reach $5B by 2022 — 4 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
